Market Research Logo

World Market for Molecular Diagnostics, 5th. Edition (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas)


Attention: There is an updated edition available for this report.

Molecular diagnostics is becoming a dominant platform in clinical medicine and represents one of the fastest growing segments of the IVD market.  As analyst Shara Rosen, R.T., MBA. details, in recent years years the number of assays introduced has been growing at a remarkable clip.  This report, The World Market for Molecular Diagnostics (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas) represents the fifth time that Kalorama has conducted a complete study into the market for molecular diagnostics.

Comprehensive Coverage of the Molecular Diagnostics Industry

The report not only contains current market data for business planning, it goes beyond the numbers to fully assess what is going on in the market and why. Since the last edition of this report, a lot has changed, and a lot has stayed the same. There is intense competition but also opportunities for entrants in some areas.   As part of its coverage, the report includes the following:
  • Over 800 Pages of Detailed Market Coverage
  • Over 55 Tables Makes Market Analysis More Accessible
  • Current Market Size and Forecast 2012-2017 for Several Molecular IVD Segments (Infectious Disease, Blood Screening, Histology, Oncology, Prenatal, Coagulation, Tissue Typing, Inherited Diseases, Pharmacodiagnostics and Other)
  • Infectious Disease Molecular Sales by Disease (Hepatitis, HIV, GC/Chlamydia, HAI, Respiratory, Organism ID, Mycobacteria/TB, others)
  • Over 200 Profiles of Molecular Diagnostic Competitors
  • Recent Mergers and Acquisitions
  • Revenues of Test Service Companies
  • Geographic Breakout of the Molecular Diagnostics Market by Region (North America, Europe, China, Japan, ROW)
  • Sample Prep Market, 2012 and 2017
  • Breakout of Molecular Histology/Cytology Market (in situ hybridization, HPV, Tissue Microarrays), 2012 and 2017
More and more laboratories offer complex panels of tests that help physicians evaluate disease risk and make therapeutic decisions. Government and private healthcare payers have recognized the value of new molecular tools and have agreed to pay for them.   A desire for better and faster test results, a preference for tests that are aimed at the patent, renewed interest in IVD in general and more particularly in molecular IVD has led to the commercialization of a number of technological tools that make more sensitive and specific tests possible. Some of these technological innovations include cost-effective, multiplexed testing platforms coupled with high-powered software capabilities. In addition analyses using saliva, urine, and blood instead of biopsied tissue make for more patient-friendly test systems.

Over 200 Companies Profiled and Ranked

Kalorama provides profiles of over 200 companies participating in the market. All of these companies have different strategies and compete in different areas, and Kalorama acknowledges this by separating the companies in a triage system based on where they stand in the molecular in vitro diagnostics market.
  • "IVD Leaders" - The top IVD companies participating in molecular diagnostics as well as dominating the rest of testing.   
  • "Molecular Diagnostics Leaders" -The top companies focused on molecular testing.  
  • "Molecular Diagnostics  Participants"- Molecular diagnostic companies that are by now established in the market
  • "Promising Companies"- Those companies that have potential with an innovative approach
  • "Molecular Diagnostics Newcomers"- IVD Companies that have novel or interesting approaches to keep an eye on
  • "Platform Innovators"- Companies that have developed new platform technologies
  • "Information Technology Companies" - Molecular testing relies on strong information systems to handle data.  These companies are in the forefront.
  • "Sample Prep Leaders" - Companies focused on sample preparation for molecular diagnostics
  • "Specialist Companies" - In various areas (microbiology, histology, blood banking, etc)

A Realistic Look at The Need-To-Know Trends

Molecular diagnostics is a complicated market that requires a thorough analysis to understand. Many reports make bold predictions which later are proved incorrect by market events. In this report, Kalorama Information provides revenues and market forecasts, but also looks deeply at some of the trends in the market and what might impact results in the future. The report summarizes what is working and what is not working in the past few years.  

  • Sequencing Hype and Reality: Innovations in DNA Sequencing, Key Players and its Future in Clinical Medicine
  • Pharmacodiagnostics and Where it Stands in 2013
  • The Latest Growth Numbers of LDTs, regulatory activity, and their impact on the Market
  • IVD Directive Update
  • Patent Issues
  • Healthcare Reform, Accountable Care Organizations and Reimbursement Trends
  • Improvements in Platforms
  • Developments in ISH testing, Tissue Microarrays and Mass Spectroscopy
  • Integrated Sample-to-Results Testing

Market size and forecasts in the report are for manufacturer's revenues. Secondary and primary resources, including: trade publications, annual report and interviews with key executives in molecular diagnostics were used for this study.  

All Kalorama reports advertise the single user price. Use is limited to one user. We also feature department and global pricing for reports that we be utilized by more than one user at your company. Please consult ask your sales representative or select the correct license on our website.

 


  • Executive Summary
    • INTRODUCTION
      • Table Common Next Generation Molecular Test Traits
      • Table Selected salient developments for now and the future
    • SCOPE AND METHODOLOGY
      • Table Exchange Rate Fluctuations, 2009-2012
    • SIZE AND GROWTH OF THE MARKET
      • Table Worldwide Molecular Test Sales, 2012-2017
    • MARKET TRENDS
  • Introduction
    • BACKGROUND
      • Table Common Next Generation Molecular Test Traits
      • Developments since 2000
        • Table Selected Salient Developments for Now and The Future
      • New Platforms
        • Table Key Molecular Technologies
        • Table Selected Nucleic Acid Testing Platforms, 2009-2012
      • Test Quality Control
        • Table Selected Sample Preparation Tools, 2012
    • BUILDING A STRONG FUTURE
      • The Service Industry Makes Gains
        • Table Revenues for a selection of molecular test service labs, worldwide, 2012, $ million (estimated)
        • Table Selected Company-Sponsored Labs, 2012
      • The $1000 Genome
      • Information Technology and "Apps"
        • Table Selected Open-Source Variant Annotation Software
        • Table Selected Information Technology Innovations in Molecular Testing
        • Table Selected App Products
      • Miniaturization and Multiplexed Assays
        • Table Selected Molecular Test Miniaturization Innovations
      • Integrated Sample-to-Results Testing
        • Table Selected Sample-to-Result Innovations
      • Mass Spectrometry
        • Table Selected Mass Specrometry Clinical Lab Applications
    • TESTS AND TECHNOLOGIES IN 2012
      • Table Worldwide Molecular Test Sales by Type, $million 2012-2017, $ million
      • Table Key Molecular Test Applications and Technologies
      • Table Selected Reference Lab and IVD Company Collaborations
  • The Commercialization Conundrum
    • BACKGROUND
    • COMMERCIALIZATION OF MOLECULAR TESTS
    • REGULATORY ISSUES AND MOLECULARASSAYS
    • PATENT LITIGATION ABOUNDS
      • Consumer, Payer and Physician Acceptance
      • Clinical Molecular Test Reimbursement Coding in The U.S.
  • Sequencing - Hype and Reality
    • BACKGROUND
      • Companies and Technologies
        • Table Major Sequencing Platforms
        • Table Selected Innovations in Sequencing
        • Table Selected Sequencing Informatics Tools
      • PCR Not Ready To Take the Back Seat
        • Table Selected PCR Testing Platforms, 2009-2012
        • Table Selected Sequencing-Based Cancer Reagents
      • Pathogen sequencing
      • Prenatal Fetal Chromosomal Analysis
  • Market Analysis: World Markets
    • BACKGROUND
    • MARKET ESTIMATE AND FORECAST BY REGION
      • Table Market Penetration Of Clinical Molecular Diagnostics, by Geographic Area (N. America, W. Europe, Japan, China, ROW), 2012-2017
    • THE UNITED STATES
      • RUO/IUO Issues
      • The Patient Protection and Affordable Care Act
      • Accountable Care Organizations
    • EUROPE
      • IVD Directive Update
    • CHINA
    • INDIA
      • Table Key Drivers for Healthcare in India
  • The Market for Blood Markers in Cancer
    • OVERVIEW
      • Methylation Patterns
      • Other Tests
    • BLOOD MOLECULAR TEST MARKET AND FORECASTS
      • LDTs
      • Radiotherapy Testing
        • Table Selected Cancer Markers, 2012
  • The Market For Molecular Assays In Hematology
    • FLOW CYTOMETRY
      • Table Selected Innovations in Molecular Hematology
  • The Market for Molecular Assays in Coagulation and Cardiac Care
    • THROMBOPHILIA SNPS
      • MTHFR
      • Factor V
      • CYP4V2
      • Market and Forecast
      • Coagulation Molecular Research Projects
    • PHARMACODIAGNOSTICS
      • Market for PGx testing
      • Plavix Testing
        • Table Selected Molecular Pharmacodiagnostics for Anticoagulant Drug Testing, 2012
  • Histology and Cytology
    • OVERVIEW
      • Table Worldwide Molecular Histology/Cytology Sales, 2012-2017 (Sales $ million)
    • IN SITU HYBRIDIZATION
      • Table Selected Molecular Histology Innovations, 2012
    • HPV TESTING
      • Table Selected HPV Test Innovations
      • Tissue Microarrays
        • Table Selected Tissue Microarray Products, 2008-2010
      • Circulating Tumor Cells
        • Table Selected Innovations in CTC Technology
        • Table Selected Flow Cytometry Innovations
      • Chromosome Analysis
        • Table Selected companies involved in chromosomal analysis of cancer cells
      • Pharmacodiagnostic Histology
        • Table Major Pharmacodiagnostic Markers
        • Table Selected Pharmacodiagnostic Histology Tests
  • Microbiology and Virology
    • OVERVIEW
    • MICROBIOLOGY MARKET AND FORECAST
      • Role of ID Testing in the Molecular Diagnostics Market
      • Markets for Specific Infectious Disease Tests
        • Table Molecular Test Sales, Microbiolog/Virology, 2012-2017
    • GENOME SEQUENCING
      • Roche, Illumina and Life
      • Other Systems
        • Table Selected Next Generation Sequencing Platforms
    • MASS SPECTROMETRY
      • Major Companies
      • Market Estimate
        • Table Selected Advanced Microbiology Platforms
    • BLOOD CULTURE
      • Table Selected Advanced Techniques for Positive Blood Cultures
      • HIV
      • Market and Forecast
    • HEPATITIS
      • Market and Forecast
      • Sexually Transmitted Diseases (STDs)
        • Table Selected New Molecular STD Assays, 2012
      • Hospital Acquired Infections (HAIs)
      • Market and Forecast
        • Table Selected Molecular HAI Test Innovations, 2012
      • Respiratory Tract Infections
        • Table Selected Molecular Tests for Respiratory Tract Infections
    • TUBERCULOSIS
      • Market and Forecast
        • Table Selected Molecular Tests for TB
    • FUNGAL INFECTIONS
      • Table Selected Molecular Tests for Fungal Infections
  • The Market for Molecular Assays in Blood Transfusion Medicine
    • BLOOD PATHOGEN SCREENING
      • Market and Forecast
    • BLOOD TYPING
      • Molecular Blood Typing
  • The Market for Molecular Assays In Organ Transplant Management
    • HLA TYPING
      • Stem Therapy Matching
      • HLA Market and Forecast
        • Table Selected HLA Typing Tests, 2012
  • The Market for Molecular Assays in Prenatal and Neonatal Testing
    • OVERVIEW
    • MARKET AND FORECAST
    • FISH TESTING
      • Other Developments
        • Table Developments in Molecular Prenatal Testing, 2012
    • NEONATAL TESTING
  • The Market for Molecular Assays for Inherited Diseases
    • Table Most Frequently Requested Genetic Tests
    • Table Selected single gene disorders
    • Table Selected Molecular Tests for Inherited Diseases, 2012
    • ARTHRITIS
    • GASTROINTESTINAL CONDITIONS
    • DIABETES
    • CARDIOVASCULAR DISEASE
      • Table Selected Innovations in Genetic Tests for CVD
    • ALZHEIMER'S DISEASE
    • PARKINSON'S DISEASE
    • PSYCHIATRIC DISORDERS
      • Table Selected Personalized Tests For CNS Diseases & Psychiatric Disorders
    • AUTISM
  • Conclusions and Strategic Implications - 2012 and beyond
    • EXPECTATIONS AND REALITIES
    • FOUR ISSUES THAT WILL IMPACT MARKET SUCCESS
  • Competitive Analysis
    • COMPANIES AND VENDORS TO WATCH
      • Table Estimated Molecular Test Revenues of Selected IVD Vendors, 2009-2012
    • ACQUISITIONS, ALLIANCES AND COLLABORATIONS
      • Table Selected Acquisitions in Molecular Diagnostics
      • Table Selected Collaborations and Licensing and Distribution Alliances
    • LOOKING BEYOND BORDERS
      • Table Selected Market Expansion Activity
  • Company Profiles: Top Tier IVD Companies' Molecular Businesses
    • ABBOTT DIAGNOSTICS
      • HLA
      • Molecular Histology
      • Companion Tests
      • Molecular Diagnostics
      • Infectious Diseases - Molecular
      • IntelligentMDx Alliance
      • PLEX-ID
    • ALERE
      • ARKRAY
    • BECKMAN COULTER INC./DANAHER
      • Instrumentation
    • BECTON, DICKINSON AND COMPANY (BD)
      • The BD MAX Enterprise
      • Viper System
      • Molecular Microbiology
      • BD GeneOhm
      • Histology
      • Oncology, etc.
    • BIOMÉRIEUX INC.
      • Molecular Oncology
      • The Biocartis Program
      • Molecular Microbiology
      • NucliSENS
      • Product Development
    • BIO-RAD LABORATORIES INC.
    • GEN-PROBE INC.
      • Product development
      • Expansion
      • Prostate Cancer
      • STDs
      • Panther System
      • HPV
      • Transplant/HLA testing
      • Infectious Diseases
      • Blood Bank
    • HOLOGIC, INC.
    • INSTRUMENTATION LABORATORY (IL)
    • ORTHO CLINICAL DIAGNOSTICS
    • QIAGEN N.V.
      • Market Expansion
      • Histology
      • Infectious diseases
      • Rotor-Gene
      • Oncology/Personalized Medicine
      • TB
      • HPV
      • HLA
      • Automation for the Future
      • Women's Health
      • Point of Care
      • Sequencing
    • ROCHE DIAGNOSTICS
      • Miscellaneous
      • Viral Load
      • STDs
      • Companion Tests
      • Sample Preparation
      • Tissue Diagnostics
      • Blood Bank
      • Sequencing
      • Microarrays
    • SIEMENS HEALTHCARE DIAGNOSTICS
      • Histology
      • Molecular
      • Sequencing
      • Companion Tests
    • SYSMEX CORPORATION
    • THERMO FISHER SCIENTIFIC INC.
      • Allergy
  • Company Profiles: Major Molecular Test Companies
    • AFFYMETRIX, INC.
      • Histology
      • Whole Genome Analysis
    • AGILENT TECHNOLOGIES INC.
      • Research Products
    • ASURAGEN, INC.
      • Oncology
      • Inherited Diseases
      • Controls
      • Sample Collection
      • Sequencing
    • BEIJING GENOME INSTITUTE (BGI)
      • BGI Projects
    • BIOFIRE DIAGNOSTICS, INC.
      • Respiratory Panel
      • Environmental Testing
    • CALIPER LIFE SCIENCES
      • Clinical Diagnostics
      • Sequencing
      • Life Sciences
    • CELERA DIAGNOSTICS
    • CEPHEID
      • Market Expansion
      • HAI
      • Personalized Medicine
      • TB
      • Infectious Diseases
    • EIKEN CHEMICAL CO., LTD
    • ENZO BIOCHEM INC.
      • ColonSentry
      • Alliances
      • IP Protection
    • EPIGENOMICSAG
    • FLUIDIGM CORPORATION
      • Prenatal
    • ILLUMINA INC.
      • BeadXpress
      • Sequencing
      • Cytogenetics
      • Sample Prep
      • PCR
      • CLIA Lab Service
    • IPSOGEN SA
    • LIFE TECHNOLOGIES
      • Ion Torrent Systems
      • Personalized Medicine
      • PCR
      • Arrays
      • IVD Company Deals
      • Life and Quidel develop diagnostics on the 7500 Fast Dx
      • Sepsis
      • HIV
      • Informatics
      • International Presence
    • NOVARTIS DIAGNOSTICS
      • Blood Bank
      • International Programs
      • Blood Typing
      • Molecular IVDs
      • Companion Tests
    • PERKINELMER, INC.
      • Prenatal and Neonatal Screening
      • Personalized Medicine
      • Molecular and Sequencing Diagnostics
      • Test Services
      • Human Health Research
    • RAINDANCE TECHNOLOGIES, INC.
      • Product Development
    • SEEGENE, INC.
      • Instrumentation
    • TRANSGENOMIC, INC.
      • Lab Services
      • Diagnostic Tools Division
      • CTCs
      • Sequencing
  • Company Profiles: Market Participants
    • ALACRIS THERANOSTICS GMBH
    • ASTRA BIOTECH GMBH
    • AUTOGENOMICS INC.
    • BIOCARTIS SA
    • BIOFORTUNA LTD.
    • BIOTYPE DIAGNOSTIC GMBH
    • BLUEGNOME
    • DIAGENICASA
    • DIAGNOCURE
    • ELITECH GROUP
    • ERAGEN BIOSCIENCES INC.
    • GENETIC TECHNOLOGIES LIMITED
    • GENMARK DIAGNOSTICS INC.
    • HELICOS BIOSCIENCES
    • IRIS INTERNATIONAL, INC.
      • Cytology
    • LUMINEX CORPORATION
      • IVD Expansion
      • Cystic Fibrosis
      • MAGPIX Multiplexing
    • MERIDIAN BIOSCIENCE, INC.
      • Bioline
    • NANOSPHERE, INC.
      • Infectious Diseases
      • Hospital Acquired Infections
    • SONY DADC BIOSCIENCES
      • Cell Sorting
      • Mass Spectrometry
    • TRIMGEN GENETIC TECHNOLOGY
    • TROVAGENE, INC.
      • Prenatal
  • Company Profiles: Promising Companies
    • AHRAM BIOSYSTEMS, INC.
    • ALLEGRO DIAGNOSTICS CORP.
    • AMOY DIAGNOSTICS CO. LTD.
    • ANAGNOSTICS BIOANALYSIS GMBH
      • Sample Preparation
    • APPLIED BIOCODE, INC.
    • ARCTICDX INC.
    • ARIOSA DIAGNOSTICS
    • AXELA INC.
    • BIOHELIX CORPORATION
    • BIONANOMATRIX/ BIONANO GENOMICS
    • BJS BIOTECHNOLOGIES
    • DIAGCOR BIOSCIENCE INC. LTD.
    • DXTERITY DIAGNOSTICS INC.
    • EPISTEM PLC
    • EXIQON A/S
    • EXONHIT
    • GENENEWS LIMITED
    • GENOME DIAGNOSTICS BV (GENDX)
    • GENOMICA S.A.U.
    • GENORAMA LTD.
    • GREAT BASIN CORPORATION
    • HEALTH DISCOVERY CORPORATION (HDC)
    • INCELLDX, INC.
    • INSIGHT GENETICS
    • INTEGENX INC.
      • Sample Transport
    • LINKAGE BIOSCIENCES, INC.
    • MED BIOGENE, INC. (MBI)
    • MULTIPLICOM
    • NABSYS, INC.
    • NANOSTRING TECHNOLOGIES, INC.
    • NIPD GENETICS LTD
    • OPTIGENE LTD
    • ORION GENOMICS
    • OXFORD GENE TECHNOLOGY (OGT)
    • PRIMERADX
    • RHEONIX INC.
    • SKYLINE DIAGNOSTICS B.V.
    • SPARTAN BIOSCIENCE INC.
    • STRATOS GENOMICS INC.
    • VOLITIONRX LIMITED
    • WAFERGEN BIOSYSTEMS, INC.
  • Company Profiles: Newcomers
    • DIASORIN S.P.A.
    • FUJIREBIO DIAGNOSTICS, INC.
    • GE HEALTHCARE
      • Cell Imaging
      • Molecular Sequencing
    • PHADIA AB
    • QUIDEL CORPORATION
      • Alliances
    • RANDOX LABORATORIES LTD.
    • TOSOH CORPORATION
    • TRANSASIA BIO-MEDICALS LTD.
  • Company Profiles: Test Platform Innovations
    • ADVANCED LIQUID LOGIC, INC. (ALL)
    • AQUILA DIAGNOSTIC SYSTEMS
    • CANON U.S. LIFE SCIENCES (CLS)
    • DNA MEDICINE INSTITUTE (DMI)
    • ESPIRA, INC.
    • GENIA TECHNOLOGIES INC.
    • GENISPHERE
    • LUMORA LTD.
    • MICHIGAN STATE UNIVERSITY
    • NOBLEGEN BIOSCIENCES
    • OXFORD NANOPORE TECHNOLOGIES LTD.
    • QUANTUMDX GROUP LIMITED
    • SENSIQ TECHNOLOGIES, INC.
    • THERMAL GRADIENT, INC.
    • VELA DIAGNOSTICS (VELADX)
  • Company Profiles: Sample Preparation
    • ARCXIS BIOTECHNOLOGIES
    • ARGYLLA TECHNOLOGIES LLC
    • BIOMATRICA, INC.
    • FLUORESENTRIC, INC.
    • NEW ENGLAND BIOLABS, INC. (NEB)
    • NORDIAG
    • NORGEN BIOTEK CORP.
    • PHTHISIS DIAGNOSTICS
    • PREANALYTIX GMBH
    • QIAGEN N.V.
    • STRECK
    • ZYGEM CORP. LTD.
  • Company Profiles: Selected Information Technology Specialists
    • ACCESS GENETICS
    • CLC BIO
    • COLLABRX, INC.
    • DEFINIENS
    • DNADIRECT
    • DIYGENOMICS
    • GENOSPACE, LLC
    • HOLGENTECH INC.
    • INGENUITY SYSTEMS
    • MEDISAPIENS LTD.
    • NEXTBIO
    • PERSONALIS
    • PORTABLE GENOMICS
    • SCICLIPS
    • SELVENTA
    • SOPHIC SYSTEMSALLIANCE
    • WELLPOINT INC.
  • Company Profiles: Microbiology Specialists
    • ADVANCED BIOLOGICAL LABORATORIES (ABL)
    • ADVANDX, INC.
    • AKONNI BIOSYSTEMS INC.
      • Sample Preparation
      • Test Systems
    • BIOMAGNETICS DIAGNOSTICS CORPORATION
    • BLACKBIO S.L.
    • BRUKER BIOSCIENCES CORPORATION
    • CAPITALBIO CORPORATION
    • CEERAM S.A.S.
    • COOPERATIVE DIAGNOSTICS, LLC
    • CURETISAG
    • ENIGMA DIAGNOSTICS LIMITED
    • FOCUS DIAGNOSTICS, INC.
    • GENOID LTD.
    • GREAT BASIN SCIENTIFIC, INC.
    • HAIN LIFESCIENCE GMBH
    • HIBERGENE DIAGNOSTICS LTD
    • IBIS BIOSCIENCES
    • ICUBATE INCORPORATED
    • IMMUNEXPRESS GROUP
    • INDEVR
    • INGEN BIOSCIENCES SA
    • INTELLIGENT MEDICAL DEVICES, INC. (IMDX)
    • IQUUM INC.
    • MIACOM DIAGNOSTICS GMBH
    • MICROPHAGE, INC.
    • MOBIDIAG LTD
    • MOLECULAR DETECTION INC. (MDI)
    • MOLZYM GMBH&CO. KG
    • MYCONOSTICA
    • NANOMR INC.
    • NETBIO
    • PATHGEN DX PTE. LTD.
    • PATHOGENE
    • PATHOGENICA
    • SIRS-LAB
    • T2 BIOSYSTEMS
  • Company Profiles: Blood Bank Specialists
    • ABSORBERAB
    • AXO SCIENCE
    • GMS BIOTECH
    • GRIFOLS, S.A.
    • IMMUCOR, INC.
    • PROGENIKA INC.
  • Company Profiles: Companies Specilaizing in Circulating Tumor Cells
    • APOCELL, INC.
    • BIOCEPT, INC.
    • CLEARBRIDGE BIOMEDICS
    • CYNVENIO BIOSYSTEMS, INC.
    • ON-Q-ITY
    • RARECYTE, INC.
    • SCREENCELL
    • VERIDEX, LLC
  • Company Profiles: Histology Specialists
    • ADVANCED CELL DIAGNOSTICS
    • BIOCARE MEDICAL, LLC
    • CHIPDX, LLC
    • CYMOGEN DX, LLC
    • DAKO A/S
      • Alliances
      • Companion Diagnostics
    • HORIZON DISCOVERY LTD
    • HTGMOLECULAR DIAGNOSTICS
      • Automation
    • MITOMICS INC.
    • NORCHIP
  • Company Profiles: Selected Test Service Providers
    • 23ANDME
    • AGENDIA BV
      • Market Expansion
      • Product News
    • ALTHEADX DIAGNOSTICS, INC.
    • AMBRY GENETICS
    • ARIA DIAGNOSTICS, INC. (FORMERLY ARIOSA DIAGNOSTICS)
    • ARUP LABORATORIES
    • ASSURERX HEALTH, INC.
    • AVESTHAGEN LIMITED
    • BIO-REFERENCE LABORATORIES, INC. (BRLI)
    • BOSTWICK LABORATORIES
    • CARDIODX, INC.
    • CARIS LIFE SCIENCES
    • CASTLE BIOSCIENCES INC.
    • CBLPATH
    • CHRONIX BIOMEDICAL INC.
    • CLARIENT INC.
    • COMBIMATRIX MOLECULAR DIAGNOSTICS, INC.
    • COMPLETE GENOMICS
    • CRESCENDO BIOSCIENCE, INC.
    • DECODE GENETICS EHF
      • Gene Variants
    • DERMAGENOMA, INC.
    • DIAGNÓSTICOS DA AMÉRICA (DASA)
    • DIATHERIX LABORATORIES INC.
    • EXACT SCIENCES CORPORATION
    • EXOSOME DIAGNOSTICS
    • GENELEX CORPORATION
    • GENETADI BIOTECH SL
    • GENOMIC HEALTH, INC.
      • Service Spin off
      • Expansion
      • Sequencing
      • Information Technology
    • GENOPTIX MEDICAL LABORATORY
    • GENOVIVE LLC
    • INOSTICS GMBH
    • INTEGRAGEN SA
    • INTERLEUKIN GENETICS, INC.
    • KNOME, INC.
    • LAB21 LIMITED
      • Services
      • Products Division
      • Expansion
    • LABORATORY CORPORATION OF AMERICA HOLDINGS (LABCORP)
    • LIFECODEXXAG
    • LINEAGEN INC.
    • LUMIGENIX
    • MAYO MEDICAL LABORATORIES
    • MDXHEALTH SA(FORMERLY ONCOMETHYLOME SCIENCES)
    • MEDICAL DIAGNOSTIC LABORATORIES L.L.C. (MDL)
    • MYRIAD GENETICS, INC.
      • Alliances
      • Test Information
      • Patent Issues
    • NATERA INC.
    • NAVIGENICS
    • NEWGENE
    • PATHWAY GENOMICS
    • PATHWORK DIAGNOSTICS
    • PGXLLABORATORIES
    • PRECISION THERAPEUTICS
    • PROMETHEUS LABORATORIES INC.
      • Patent Issues
    • QUEST DIAGNOSTICS
      • Information Technology
    • RIDGE DIAGNOSTICS, INC.
    • ROSETTA GENOMICS LTD.
    • RULES-BASED MEDICINE, INC. (RBM)
    • SEQUENOM INC.
      • Sequenom Center for Molecular Medicine
      • Market Expansion
      • Prenatal Patent
      • Genetic Analysis Products
    • SEQUENTA, INC.
    • SIGNAL GENETICS
    • SONIC HEALTHCARE
    • SUREGENE, LLC
    • VERACYTE. INC.
    • VERINATA HEALTH, INC.
    • XDX INC. - EXPRESSION DIAGNOSTICS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report